Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

L-Carnitine and Increased HDL Cholesterol Levels

Research synthesisLow evidenceSmall effect3 studies · 1 beneficial · 2 neutral · 0 harmful

Across 3 studies, only 1 (an umbrella meta-analysis) reported a small statistically significant beneficial effect of L-carnitine on HDL cholesterol, while 2 randomized controlled trials found no significant effect. The predominant effect size is small, and the median study duration was 77 days (about 11 weeks). The evidence base is too limited to draw firm conclusions about dose or population.

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. Only one study (an umbrella meta-analysis) reached statistical significance, while two RCTs did not, suggesting the effect may be inconsistent or smaller than the beneficial direction implies. The two RCTs were conducted in clinical populations (PCOS, children on hemodialysis), which may limit generalizability to healthy adults. Doses varied widely (1000 mg/day, >2 g/day, 50 mg/kg/day) and no form data were reported.

Generated Jul 15, 2026
Doses used in studies
  • g/day: 2 (median 2, IQR 2–2) — 1 study
  • mg/day: 1,000 (median 1,000, IQR 1,000–1,000) — 1 study
  • mg/kg/day: 50 (median 50, IQR 50–50) — 1 study
Time to effect
Median: 11 weeks · IQR 10.5 weeks–11.5 weeks · Range 10 weeks–2.8 months — Reported in 2 of 3 studies
3 of 3 papers
Back to top